Literature DB >> 12654637

Pulmonary vascular permeability and ischemic injury in gelsolin-deficient mice.

Patrice M Becker1, Armina A Kazi, Raj Wadgaonkar, David B Pearse, David Kwiatkowski, Joe G N Garcia.   

Abstract

Gelsolin is a potent actin filament regulatory protein that controls cytoskeletal assembly and disassembly. Because cellular gelsolin deficiency leads to pronounced actin stress fiber formation and defective chemotaxis, and similar cytoskeletal remodeling results in endothelial barrier dysfunction, we hypothesized that gelsolin deficient mice would exhibit increased vascular permeability. To test this hypothesis, we compared baseline lung lavage (BAL) protein concentration, wet/dry weight ratio, and osmotic reflection coefficient for albumin (sigma alb) in gelsolin-deficient (gsn-/-) and C57BL/6 (wild-type) mice. In addition, we assessed lung permeability in response to ischemia by evaluating BAL protein concentration after 4, 8, or 24 h of left pulmonary arterial (LPA) occlusion, and lung wet/dry weight ratio and histology after 24 h of LPA occlusion, in gsn-/- and wild-type animals, as compared with control and sham-operated mice. Baseline measurements revealed that BAL protein concentration was 18-fold higher in gsn-/- than in wild-type mice, whereas sigma alb averaged 0.62 + 0.15 in wild-type, as compared with 0.31 + 0.05 in gsn-/- animals, indicating that gelsolin deficiency caused increased pulmonary vascular permeability. Ischemia increased lung permeability (BAL protein and lung wet/dry weight) in both wild-type and gsn-/- mice. However, whereas the fold-increase in BAL protein concentration was less in gsn-/- mice (2- to 4-fold) as compared with wild-type (22- to 34-fold), the duration of ischemia-induced permeability changes was prolonged. Lung wet/dry weight and gross histology following ischemia were comparable in wild-type and gsn-/- animals. These data suggest that gelsolin significantly contributes to maintenance of vascular barrier function in the lung.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654637     DOI: 10.1165/rcmb.2002-0024OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  17 in total

1.  Direct factor Xa inhibition attenuates acute lung injury progression via modulation of the PAR-2/NF-κB signaling pathway.

Authors:  Meng Shi; Linlin Wang; Jian Zhou; Shimeng Ji; Ningfang Wang; Lin Tong; Jing Bi; Yuanlin Song; Jie Hu; Xiaofeng Chen
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

Review 2.  Actin dynamics in the regulation of endothelial barrier functions and neutrophil recruitment during endotoxemia and sepsis.

Authors:  Michael Schnoor; Alexander García Ponce; Eduardo Vadillo; Rosana Pelayo; Jan Rossaint; Alexander Zarbock
Journal:  Cell Mol Life Sci       Date:  2017-02-02       Impact factor: 9.261

3.  Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.

Authors:  Young Ah Goo; Kevin Cain; Monica Jarrett; Lynne Smith; Joachim Voss; Ernie Tolentino; Joyce Tsuji; Yihsuan S Tsai; Alexandre Panchaud; David R Goodlett; Robert J Shulman; Margaret Heitkemper
Journal:  J Proteome Res       Date:  2012-10-26       Impact factor: 4.466

4.  Protective role of PI3-kinase/Akt/eNOS signaling in mechanical stress through inhibition of p38 mitogen-activated protein kinase in mouse lung.

Authors:  Xin-qi Peng; Mahendra Damarla; Jarrett Skirball; Stephanie Nonas; Xiao-ying Wang; Eugenia J Han; Emile J Hasan; Xuan Cao; Adel Boueiz; Rachel Damico; Rubin M Tuder; Alfred M Sciuto; Dana R Anderson; Joe G N Garcia; David A Kass; Paul M Hassoun; Jun-tian Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-02       Impact factor: 6.150

5.  A direct interaction with calponin inhibits the actin-nucleating activity of gelsolin.

Authors:  Imen Ferjani; Abdellatif Fattoum; Sutherland K Maciver; Christine Bénistant; Anne Chahinian; Mohamed Manai; Yves Benyamin; Claude Roustan
Journal:  Biochem J       Date:  2006-06-15       Impact factor: 3.857

6.  The role of caveolin-1 in pulmonary matrix remodeling and mechanical properties.

Authors:  O Le Saux; K Teeters; S Miyasato; J Choi; G Nakamatsu; J A Richardson; B Starcher; E C Davis; E K Tam; C Jourdan-Le Saux
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-10       Impact factor: 5.464

7.  Differential regulation of sphingosine kinases 1 and 2 in lung injury.

Authors:  Raj Wadgaonkar; Vipul Patel; Natalia Grinkina; Carol Romano; Jing Liu; Yutong Zhao; Saad Sammani; Joe G N Garcia; Viswanathan Natarajan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-23       Impact factor: 5.464

8.  The protective effects of plasma gelsolin on stroke outcome in rats.

Authors:  Huong T Le; Aaron C Hirko; Jeffrey S Thinschmidt; Maria Grant; Zhimin Li; Joanna Peris; Michael A King; Jeffrey A Hughes; Sihong Song
Journal:  Exp Transl Stroke Med       Date:  2011-11-02

9.  Reduction of plasma gelsolin levels correlates with development of multiple organ dysfunction syndrome and fatal outcome in burn patients.

Authors:  Li-feng Huang; Yong-ming Yao; Jin-feng Li; Ning Dong; Chen Liu; Yan Yu; Li-xin He; Zhi-yong Sheng
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

10.  Circulating histones are mediators of trauma-associated lung injury.

Authors:  Simon T Abrams; Nan Zhang; Joanna Manson; Tingting Liu; Caroline Dart; Florence Baluwa; Susan Siyu Wang; Karim Brohi; Anja Kipar; Weiping Yu; Guozheng Wang; Cheng-Hock Toh
Journal:  Am J Respir Crit Care Med       Date:  2012-12-06       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.